312 related articles for article (PubMed ID: 34560539)
21. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
Namasivayam S; Sher A; Glickman MS; Wipperman MF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
[TBL] [Abstract][Full Text] [Related]
22. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
Gordhan BG; Peters J; Kana BD
Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
[TBL] [Abstract][Full Text] [Related]
23. Integrating Lung Physiology, Immunology, and Tuberculosis.
Torrelles JB; Schlesinger LS
Trends Microbiol; 2017 Aug; 25(8):688-697. PubMed ID: 28366292
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
Negi S; Pahari S; Bashir H; Agrewala JN
Front Immunol; 2019; 10():1142. PubMed ID: 31231363
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis: a disease without boundaries.
Fogel N
Tuberculosis (Edinb); 2015 Sep; 95(5):527-31. PubMed ID: 26198113
[TBL] [Abstract][Full Text] [Related]
26. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.
Cadena AM; Ma Y; Ding T; Bryant M; Maiello P; Geber A; Lin PL; Flynn JL; Ghedin E
Microbiome; 2018 Oct; 6(1):180. PubMed ID: 30301469
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.
Wipperman MF; Fitzgerald DW; Juste MAJ; Taur Y; Namasivayam S; Sher A; Bean JM; Bucci V; Glickman MS
Sci Rep; 2017 Sep; 7(1):10767. PubMed ID: 28883399
[TBL] [Abstract][Full Text] [Related]
28. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
29. TB meets COPD: An emerging global co-morbidity in human lung disease.
O'Toole RF; Shukla SD; Walters EH
Tuberculosis (Edinb); 2015 Dec; 95(6):659-663. PubMed ID: 26386744
[TBL] [Abstract][Full Text] [Related]
30. Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing.
Xiao G; Cai Z; Guo Q; Ye T; Tang Y; Guan P; Zhang J; Ou M; Fu X; Ren L; Yu M; Wang Z; Liu L; Yang L; Zhang G
Microbiol Spectr; 2022 Feb; 10(1):e0190121. PubMed ID: 35196800
[TBL] [Abstract][Full Text] [Related]
31. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
Gupta N; Kumar R; Agrawal B
Front Immunol; 2018; 9():709. PubMed ID: 29692778
[TBL] [Abstract][Full Text] [Related]
32. The Gut Microbiota and Respiratory Diseases: New Evidence.
Chunxi L; Haiyue L; Yanxia L; Jianbing P; Jin S
J Immunol Res; 2020; 2020():2340670. PubMed ID: 32802893
[TBL] [Abstract][Full Text] [Related]
33. The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases.
Shah T; Baloch Z; Shah Z; Cui X; Xia X
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34202945
[TBL] [Abstract][Full Text] [Related]
34. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
35. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
[TBL] [Abstract][Full Text] [Related]
36. Role of microbiota on lung homeostasis and diseases.
Wang J; Li F; Tian Z
Sci China Life Sci; 2017 Dec; 60(12):1407-1415. PubMed ID: 29019144
[TBL] [Abstract][Full Text] [Related]
37. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.
Kim S; Covington A; Pamer EG
Immunol Rev; 2017 Sep; 279(1):90-105. PubMed ID: 28856737
[TBL] [Abstract][Full Text] [Related]
38. Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study.
Hu Y; Cheng M; Liu B; Dong J; Sun L; Yang J; Yang F; Chen X; Jin Q
Emerg Microbes Infect; 2020 Dec; 9(1):1444-1452. PubMed ID: 32552447
[TBL] [Abstract][Full Text] [Related]
39. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.
Zhang X; Xie Q; Ye Z; Li Y; Che Z; Huang M; Zeng J
Front Immunol; 2021; 12():695278. PubMed ID: 34367155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
